StonvexLoading…
StonvexStonvexStonvexCore line items from ARBE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.03M | $768.00K | $1.47M | $3.52M |
Operating Income | $-48.20M | $-49.65M | $-46.88M | $-47.73M |
Net Income | $-46.42M | $-49.32M | $-43.50M | $-40.49M |
EPS (Diluted) | $-0.42 | $-0.61 | $-0.61 | $-0.66 |
Total Assets | $73.85M | $60.79M | $50.48M | $60.83M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.03M | $13.49M | $28.59M | $54.17M |
Free Cash Flow OCF − CapEx | $-38.43M | $-33.12M | $-33.76M | $-41.28M |
Shares Outstanding | 109.19M | 85.75M | 77.93M | 64.16M |